Kidney Involvement in Patients With Chronic Myelomonocytic Leukemia or BCR-ABL–Negative Myeloproliferative Neoplasms

INTRODUCTION: The identification of specific molecular signatures and the development of new targeted drugs have changed the paradigm of onco-nephrology, now allowing a multiscale approach of kidney involvement related to hematologic malignancies relying on combined hematologic and molecular assessm...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Kidney Int Rep
Glavni autori: Belliere, Julie, Colombat, Magali, Kounde, Clément, Recher, Christian, Ribes, David, Huart, Antoine, Chauveau, Dominique, Demas, Véronique, Luquet, Isabelle, Beyne-Rauzy, Odile, Tavitian, Suzanne, Faguer, Stanislas
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Clinical Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938079/
https://ncbi.nlm.nih.gov/pubmed/33732988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.12.005
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items